MACK - MERRIMACK PHARMACEUTICALS INC


15.13
0   0%

Share volume: 1,255,765
Last Updated: 05-17-2024

PREVIOUS CLOSE
CHG
CHG%

$15.13
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Company vs Stock growth
vs
Performance
5 Days
1.25%
1 Month
3.05%
3 Months
-4.40%
6 Months
2.01%
1 Year
180.18%
2 Year
126.87%
Key data
Stock price
$15.13
P/E Ratio 
0.00
DAY RANGE
$15.13 - $15.16
EPS 
$0.00
52 WEEK RANGE
$3.00 - $13.66
52 WEEK CHANGE
$1.85
MARKET CAP 
174.143 M
YIELD 
N/A
SHARES OUTSTANDING 
14.321 M
DIVIDEND
$1.4967
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-0.84
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$101,203
AVERAGE 30 VOLUME 
$78,050
Company detail
CEO: Gary L. Crocker
Region: US
Website: merrimack.com
Employees: 27
IPO year: 2012
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Recent news